Diabetes screening overhaul could cut GP workload

Using HbA1c to screen for diabetes in pharmacies could identify undiagnosed cases without generating unnecessary GP referrals, researchers believe.

Professor Kamlesh Khunti, professor of primary care diabetes at the University of Leicester and a GP in the city, is leading a study to assess the effectiveness of this approach.

‘We want to reduce the number of people who go to their GP for a test,’ he said.

Patients will be asked to complete a risk assessment in a community pharmacy.

‘On the basis of a high-risk score, half will be asked to see their GP,’ Professor Khunti said. ‘The other half will have a finger-prick test of HbA1c at the pharmacy.’

Those given tests in the pharmacy and found to have elevated HbA1c levels would then be referred to their GP for a second test, he said. Since two elevated HbA1c tests are required for a diagnosis of diabetes, these patients will need just one test at their GP practice.

Patients not found to have elevated HbA1c levels by the pharmacy can be reassured and offered lifestyle advice. This reduces the need for patients to be referred to their GP on the basis of the risk assessment.

Professor Khunti said that previous work on cardiovascular risk screening in pharmacies highlighted the need for such schemes to reduce, rather than increase, GP workload.

‘We found that pharmacists loved it and patients loved it, but that some GPs weren’t so sure, because we had a lot of duplication of work,’ he said. ‘We want a system where there isn’t a lot of duplication.’

As well as avoiding GP appointments, using pharmacies as screening venues offers the potential to reach a broad section of the population.

‘A lot of people go to pharmacies but don’t go to their GP,’ Professor Khunti said.

The 2,000-patient randomised controlled trial has so far recruited about a third of the necessary patients.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Common conditions in skin of colour

Common conditions in skin of colour

An essential guide to common dermatoses and their presentations in skin of colour.

Common asthma drug speeds up COVID-19 recovery in community for high-risk patients

Common asthma drug speeds up COVID-19 recovery in community for high-risk patients

A common corticosteroid shortens COVID-19 recovery times for patients aged over 50...

Salaried GPs must not be coerced into vaccinating for free, BMA warns

Salaried GPs must not be coerced into vaccinating for free, BMA warns

Salaried GPs should not be coerced into unpaid work for the COVID-19 vaccination...

Delayed risk assessments may have cost BAME doctors' lives, BMA chair warns

Delayed risk assessments may have cost BAME doctors' lives, BMA chair warns

Delayed risk assessments may have contributed to disproportionate deaths among doctors...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...